MGP
BMY icon

M&G plc’s Bristol-Myers Squibb BMY Stock Holding History

M&G plc’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$307M Sell
5,292,229
-471,911
-8% -$27.1M 1.53% 12
2026
Q1 		$352M Sell
5,764,140
-1,371,341
-19% -$79.9M 1.82% 10
2025
Q4 		$385M Buy
7,135,481
+250,293
+4% +$12M 1.98% 7
2025
Q3 		$310M Buy
6,885,188
+97,063
+1% +$4.53M 1.65% 9
2025
Q2 		$312M Sell
6,788,125
-68,014
-1% -$3.34M 1.72% 11
2025
Q1 		$418M Sell
6,856,139
-1,019,354
-13% -$59.4M 2% 6
2024
Q4 		$449M Sell
7,875,493
-1,308,435
-14% -$73.1M 2.77% 5
2024
Q3 		$478M Sell
9,183,928
-567,099
-6% -$26.6M 1.72% 9
2024
Q2 		$410M Buy
9,751,027
+2,480,515
+34% +$111M 1.62% 9
2024
Q1 		$393M Buy
+7,270,512
New +$370M 1.48% 8

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

M&G plc's BMY Position: Q2 2026 in Review

M&G plc reduced its Bristol-Myers Squibb (BMY) stake by 8.2% in Q2 2026, selling an estimated $27.1M and leaving 5,292,229 shares worth $307M. The position accounts for 1.53% of the portfolio, ranked #12.

M&G plc first reported a position in BMY in Q1 2024 and has held it in 10 quarters since. The position peaked at $478M in Q3 2024. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • M&G plc held 5,292,229 shares of Bristol-Myers Squibb worth $307M as of Q2 2026.
  • M&G plc sold 471,911 Bristol-Myers Squibb shares in Q2 2026, an estimated $27.1M.
  • Bristol-Myers Squibb made up 1.53% of M&G plc's portfolio in Q2 2026, its #12 holding.
  • M&G plc first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 10 quarters since.
  • M&G plc's Bristol-Myers Squibb position peaked at $478M in Q3 2024.
  • 2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on M&G plc's 13F filing for Q2 2026, filed 6 Aug 2026.